Anti-CDC20 monoclonal antibody
Pre-made anti-CDC20 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to CDC20/CDC20 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T85241-Ab-1/ GM-Tg-hg-T85241-Ab-2 | Anti-Human CDC20 monoclonal antibody | Human |
GM-Tg-rg-T85241-Ab-1/ GM-Tg-rg-T85241-Ab-2 | Anti-Rat CDC20 monoclonal antibody | Rat |
GM-Tg-mg-T85241-Ab-1/ GM-Tg-mg-T85241-Ab-2 | Anti-Mouse CDC20 monoclonal antibody | Mouse |
GM-Tg-cynog-T85241-Ab-1/ GM-Tg-cynog-T85241-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CDC20 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T85241-Ab-1/ GM-Tg-felg-T85241-Ab-2 | Anti-Feline CDC20 monoclonal antibody | Feline |
GM-Tg-cang-T85241-Ab-1/ GM-Tg-cang-T85241-Ab-2 | Anti-Canine CDC20 monoclonal antibody | Canine |
GM-Tg-bovg-T85241-Ab-1/ GM-Tg-bovg-T85241-Ab-2 | Anti-Bovine CDC20 monoclonal antibody | Bovine |
GM-Tg-equg-T85241-Ab-1/ GM-Tg-equg-T85241-Ab-2 | Anti-Equine CDC20 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T85241-Ab-1/ GM-Tg-hg-T85241-Ab-2; GM-Tg-rg-T85241-Ab-1/ GM-Tg-rg-T85241-Ab-2; GM-Tg-mg-T85241-Ab-1/ GM-Tg-mg-T85241-Ab-2; GM-Tg-cynog-T85241-Ab-1/ GM-Tg-cynog-T85241-Ab-2; GM-Tg-felg-T85241-Ab-1/ GM-Tg-felg-T85241-Ab-2; GM-Tg-cang-T85241-Ab-1/ GM-Tg-cang-T85241-Ab-2; GM-Tg-bovg-T85241-Ab-1/ GM-Tg-bovg-T85241-Ab-2; GM-Tg-equg-T85241-Ab-1/ GM-Tg-equg-T85241-Ab-2 |
Products Name | Anti-CDC20 monoclonal antibody |
Format | mab |
Target Name | CDC20 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-CDC20 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T85241-Ag-1 | Recombinant multi-species CDC20/ CDC20A/ bA276H19.3 protein |
ORF Viral Vector | vGMLP002664 | human CDC20 Lentivirus particle |
ORF Viral Vector | pGMLP002664 | human CDC20 Lentivirus plasmid |
ORF Viral Vector | pGMAAV000206 | house mouse Cdc20 AAV plasmid |
ORF Viral Vector | pGMLPm002113 | mouse Cdc20 Lentivirus plasmid |
ORF Viral Vector | vGMAAV000206 | house mouse Cdc20 AAV particle |
ORF Viral Vector | vGMLPm002113 | mouse Cdc20 Lentivirus particle |
Target information
Target ID | GM-T85241 |
Target Name | CDC20 |
Gene ID | 991,107995,64515,100855774,101097259,515376,100053348 |
Gene Symbol and Synonyms | 2310042N09Rik,bA276H19.3,CDC20,CDC20A,OOMD14,OZEMA14,p55CDC |
Uniprot Accession | Q12834,Q62623 |
Uniprot Entry Name | CDC20_HUMAN,CDC20_RAT |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Breast Cancer |
Gene Ensembl | ENSG00000117399 |
Target Classification | N/A |
The target: CDC20, gene name: CDC20, also named as CDC20A, bA276H19.3, p55CDC. CDC20 appears to act as a regulatory protein interacting with several other proteins at multiple points in the cell cycle. It is required for two microtubule-dependent processes, nuclear movement prior to anaphase and chromosome separation. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.